Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -89.99%-10.55M | ---- | 67.98%-5.55M | ---- | -57.11%-17.34M | ---- | 36.26%-11.04M | ---- | -24.58%-17.32M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 55.81%-19K | ---- | 32.81%-43K | ---- | 61.21%-64K | ---- | -20.44%-165K | ---- | 27.89%-137K |
| Interest expense - adjustment | ---- | 3.59%1.47M | ---- | 117.10%1.42M | ---- | 50.57%655K | ---- | -31.71%435K | ---- | -16.07%637K |
| Impairment and provisions: | ---- | 116.23%1.03M | ---- | -325.46%-6.36M | ---- | 59.50%2.82M | ---- | -61.46%1.77M | ---- | 328.29%4.59M |
| -Impairmen of inventory (reversal) | ---- | 104.97%274K | ---- | -459.95%-5.52M | ---- | -30.73%1.53M | ---- | 89.47%2.21M | ---- | 324.73%1.17M |
| -Impairment of trade receivables (reversal) | ---- | 88.81%-94K | ---- | -165.27%-840K | ---- | --1.29M | ---- | ---- | ---- | 329.52%3.42M |
| -Other impairments and provisions | ---- | --852K | ---- | ---- | ---- | ---- | ---- | ---445K | ---- | ---- |
| Revaluation surplus: | ---- | -101.42%-31K | ---- | 1,613.89%2.18M | ---- | 78.41%-144K | ---- | 81.55%-667K | ---- | -2,702.33%-3.62M |
| -Other fair value changes | ---- | -101.42%-31K | ---- | 1,613.89%2.18M | ---- | 78.41%-144K | ---- | 81.55%-667K | ---- | -2,702.33%-3.62M |
| Depreciation and amortization: | ---- | -20.50%861K | ---- | 7.65%1.08M | ---- | -15.25%1.01M | ---- | -60.77%1.19M | ---- | -32.23%3.03M |
| -Amortization of intangible assets | ---- | -89.83%12K | ---- | -43.27%118K | ---- | 1.96%208K | ---- | -11.30%204K | ---- | -22.82%230K |
| Unrealized exchange loss (gain) | ---- | 76.99%777K | ---- | -85.17%439K | ---- | 371.90%2.96M | ---- | 54.72%-1.09M | ---- | -439.21%-2.41M |
| Special items | ---- | ---117K | ---- | ---- | ---- | -476.47%-64K | ---- | 111.26%17K | ---- | -938.89%-151K |
| Operating profit before the change of operating capital | ---- | 3.75%-6.57M | ---- | 32.86%-6.83M | ---- | -6.49%-10.17M | ---- | 37.87%-9.55M | ---- | -113.61%-15.38M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 73.42%12.52M | ---- | -4.90%7.22M | ---- | 212.69%7.59M | ---- | -189.79%-6.74M | ---- | 3,213.69%7.5M |
| Accounts receivable (increase)decrease | ---- | 229.89%3.71M | ---- | -163.58%-2.85M | ---- | 145.57%4.49M | ---- | -78.43%1.83M | ---- | 859.50%8.48M |
| Accounts payable increase (decrease) | ---- | -326.17%-4.56M | ---- | 67.20%-1.07M | ---- | -171.21%-3.26M | ---- | 502.55%4.58M | ---- | -173.23%-1.14M |
| Special items for working capital changes | ---- | -267.57%-3.66M | ---- | 104.87%2.19M | ---- | 733.59%1.07M | ---- | -96.56%128K | ---- | 193.59%3.73M |
| Cash from business operations | ---- | 206.38%1.43M | ---- | -370.98%-1.35M | ---- | 97.07%-286K | ---- | -405.58%-9.75M | ---- | 129.07%3.19M |
| Other taxs | ---- | 146.88%15K | ---- | ---32K | ---- | ---- | ---- | -91.90%59K | ---- | 133.00%728K |
| Interest paid - operating | ---- | 5.16%-975K | ---- | -56.95%-1.03M | ---- | -54.85%-655K | ---- | 11.51%-423K | ---- | 22.65%-478K |
| Special items of business | -160.39%-2.52M | ---- | -281.09%-967K | ---- | 29.61%534K | ---- | 58.46%412K | ---- | -89.17%260K | ---- |
| Net cash from operations | -160.39%-2.52M | 119.65%473K | -281.09%-967K | -155.79%-2.41M | 29.61%534K | 90.70%-941K | 58.46%412K | -393.96%-10.12M | -89.17%260K | 124.93%3.44M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -76.74%10K | ---- | -32.81%43K | ---- | -61.21%64K | ---- | 20.44%165K | ---- | -27.89%137K |
| Purchase of fixed assets | ---- | 95.15%-16K | ---- | ---330K | ---- | ---- | ---- | ---230K | ---- | ---- |
| Purchase of intangible assets | ---- | ---195K | ---- | ---- | ---- | -14.29%-16K | ---- | ---14K | ---- | ---- |
| Other items in the investment business | -323.81%-47K | ---- | 1,150.00%21K | ---- | -128.57%-2K | ---- | 106.31%7K | ---- | -341.30%-111K | ---- |
| Net cash from investment operations | -323.81%-47K | 29.97%-201K | 1,150.00%21K | -697.92%-287K | -128.57%-2K | 160.76%48K | 106.31%7K | -157.66%-79K | -341.30%-111K | 129.34%137K |
| Net cash before financing | -171.14%-2.57M | 110.10%272K | -277.82%-946K | -201.68%-2.69M | 26.97%532K | 91.24%-893K | 181.21%419K | -384.91%-10.2M | -93.91%149K | 125.08%3.58M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -15.33%26.17M | ---- | -4.42%30.91M | ---- | 7.39%32.34M | ---- | 10.52%30.11M | ---- | 73.79%27.25M |
| Refund | ---- | 14.83%-25.11M | ---- | -12.37%-29.48M | ---- | 7.26%-26.24M | ---- | -27.16%-28.29M | ---- | -136.52%-22.25M |
| Other items of the financing business | 59.79%-1.02M | ---- | -4.94%-2.53M | ---- | -243.42%-2.41M | ---- | 529.41%1.68M | ---- | -136.34%-391K | ---- |
| Net cash from financing operations | 59.79%-1.02M | 1.65%556K | -4.94%-2.53M | -90.39%547K | -243.42%-2.41M | 363.68%5.69M | 529.41%1.68M | -62.84%1.23M | -136.34%-391K | -9.33%3.31M |
| Effect of rate | ---- | -56.72%-105K | ---- | -97.06%-67K | ---- | -312.50%-34K | ---- | 300.00%16K | ---- | 94.63%-8K |
| Net Cash | -3.11%-3.58M | 138.57%828K | -85.13%-3.47M | -144.72%-2.15M | -189.42%-1.88M | 153.53%4.8M | 966.94%2.1M | -230.29%-8.97M | -106.87%-242K | 164.77%6.88M |
| Begining period cash | 9.71%8.17M | -22.92%7.45M | -22.92%7.45M | 97.44%9.66M | 97.44%9.66M | -64.67%4.89M | -64.67%4.89M | 98.67%13.85M | 98.67%13.85M | -60.73%6.97M |
| Cash at the end | 15.48%4.59M | 9.71%8.17M | -48.97%3.97M | -22.92%7.45M | 11.34%7.78M | 97.44%9.66M | -48.61%6.99M | -64.67%4.89M | 29.65%13.6M | 98.67%13.85M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.